Twitter

Areas of care

Non-invasive white blood cell count in under a minute

Neosonics© is a first-in-class medical device that non-invasively counts white blood cells in serous fluid, enabling fast, easy and cost-effective screening, diagnosis and monitoring of serous fluid infections. It combines high-resolution ultrasound, unique coupling materials, and deep learning AI algorithms.
PURPOSE AND IMPACT
Documents icon

Proven effectiveness

We develop solutions with renowned experts and hospitals from around the world for patients with suspected serous fluid infections that provide an accurate, non-invasive, easy-to-use solution, and allow fast and agile action.
patient care icon

Democratic accessibility

Our low-cost technology solutions democratize access to accurate diagnosis with a global reach, while contributing to the sustainability of healthcare systems everywhere.
Position icon

Accelerated impact

Our medical device delivers real-time, relevant clinical data, empowering healthcare professionals around the world with innovation by enabling fast, easy and cost-effective non-invasive screening, monitoring and diagnosis of serous fluid infections.

Newborn

Screen and monitor for meningitis in newborn and babies with an open fontanel
Newborn feet up-close
Newborn feet up-close
Older couple sharing a happy moment lying down at home
Older couple sharing a happy moment lying down at home

Kidney

Screen and monitor for peritonitis in domiciliary peritoneal dialysis

Eye care

Early detection and quantitative monitoring of uveitis
Female patient in an ophtalmologist's slit lamp with chin rest
Female patient in an ophtalmologist's slit lamp with chin rest

Download Brochure

If you want to know more, download the Kriba brochure and all its medical devices.
DOWNLOAD BROCHURE

Download
our brochure

Fill out the form and click to download.
WARNING

Are you a healthcare
professional?

The content featured on this site is exclusively addressed to healthcare and medical technology specialists. The following products are under development and/or validation processes and they are not ready for commercialization.